- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-16-mer
- Ligands
- 12 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 10 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.3: 15 residues within 4Å:- Chain A: I.162, S.164, S.165, R.166, D.167, T.185, D.189, L.190, V.191, K.211, G.212, K.213
- Chain F: R.229
- Ligands: GTP.1, ATP.27
12 PLIP interactions:11 interactions with chain A, 1 interactions with chain F- Hydrogen bonds: A:S.164, A:S.164, A:S.165, A:D.167, A:V.191, A:K.211, A:K.213, A:K.213
- Salt bridges: A:R.166, A:R.166, A:R.166, F:R.229
ATP.8: 16 residues within 4Å:- Chain B: I.162, S.164, S.165, R.166, D.167, T.185, D.189, L.190, V.191, K.211, G.212, K.213
- Chain E: R.166, K.233
- Ligands: GTP.6, ATP.22
18 PLIP interactions:14 interactions with chain B, 4 interactions with chain E- Hydrogen bonds: B:S.164, B:S.165, B:D.167, B:D.167, B:T.185, B:V.191, B:K.211, B:K.213, B:K.213, E:R.166
- Salt bridges: B:R.166, B:R.166, B:R.166, B:K.213, B:K.213, E:R.166, E:R.166, E:K.233
ATP.11: 14 residues within 4Å:- Chain C: I.162, S.164, S.165, R.166, D.167, T.185, L.190, V.191, K.211, G.212, K.213, P.215
- Chain H: R.166
- Ligands: ATP.12
12 PLIP interactions:10 interactions with chain C, 2 interactions with chain H- Hydrogen bonds: C:S.164, C:S.165, C:R.166, C:D.167, C:T.185, C:K.211, C:G.212, C:K.213, C:K.213
- pi-Cation interactions: C:K.211
- Salt bridges: H:R.166, H:K.233
ATP.12: 11 residues within 4Å:- Chain C: I.120, D.122, P.123, G.143, F.144, C.145, G.146, A.228, R.229, T.230
- Ligands: ATP.11
8 PLIP interactions:8 interactions with chain C- Hydrogen bonds: C:C.145, C:G.146, C:G.146, C:R.229, C:T.230, C:T.230
- pi-Stacking: C:F.144, C:F.144
ATP.17: 16 residues within 4Å:- Chain D: I.162, S.164, S.165, R.166, T.185, D.189, L.190, V.191, K.211, G.212, K.213, P.215
- Chain G: R.166, K.210
- Ligands: GTP.15, ATP.30
11 PLIP interactions:7 interactions with chain D, 4 interactions with chain G- Hydrogen bonds: D:S.164, D:S.165, D:V.191, D:K.213, D:K.213, G:K.210, G:K.210
- Salt bridges: D:R.166, D:R.166, G:R.166, G:R.166
ATP.22: 17 residues within 4Å:- Chain B: R.166, K.210, R.229
- Chain E: S.164, S.165, R.166, D.167, T.185, D.189, L.190, V.191, K.211, G.212, K.213, P.215
- Ligands: ATP.8, GTP.20
12 PLIP interactions:9 interactions with chain E, 3 interactions with chain B- Hydrogen bonds: E:S.164, E:S.165, E:D.167, E:V.191, E:V.191, E:K.213, B:R.166
- Salt bridges: E:R.166, E:R.166, E:R.166, B:R.166, B:R.229
ATP.27: 15 residues within 4Å:- Chain A: R.166
- Chain F: I.162, S.164, S.165, R.166, D.167, T.185, D.189, L.190, V.191, K.211, G.212, K.213
- Ligands: ATP.3, GTP.25
13 PLIP interactions:10 interactions with chain F, 3 interactions with chain A- Hydrogen bonds: F:S.164, F:S.165, F:V.191, F:K.213, F:K.213, A:R.166
- Salt bridges: F:R.166, F:R.166, F:R.166, F:K.213, F:K.213, A:R.166, A:K.233
ATP.30: 16 residues within 4Å:- Chain D: R.166
- Chain G: I.162, S.164, S.165, R.166, D.167, T.185, L.190, V.191, K.211, G.212, K.213, L.214, P.215
- Ligands: ATP.17, ATP.31
13 PLIP interactions:2 interactions with chain D, 11 interactions with chain G- Salt bridges: D:R.166, D:K.233
- Hydrogen bonds: G:S.164, G:S.165, G:S.165, G:R.166, G:R.166, G:D.167, G:K.211, G:G.212, G:K.213, G:K.213
- pi-Cation interactions: G:K.211
ATP.31: 12 residues within 4Å:- Chain G: I.120, D.122, P.123, V.124, G.143, F.144, C.145, G.146, S.165, A.228, T.230
- Ligands: ATP.30
9 PLIP interactions:9 interactions with chain G- Hydrogen bonds: G:V.124, G:C.145, G:G.146, G:S.165, G:T.230, G:T.230, G:T.230
- pi-Stacking: G:F.144, G:F.144
ATP.36: 14 residues within 4Å:- Chain C: R.166, K.210
- Chain H: I.162, S.164, S.165, R.166, T.185, D.189, L.190, V.191, K.211, G.212, K.213
- Ligands: GTP.34
12 PLIP interactions:9 interactions with chain H, 3 interactions with chain C- Hydrogen bonds: H:S.164, H:S.165, H:R.166, H:T.185, H:T.185, H:V.191, H:K.213, H:K.213, C:K.210, C:K.210
- Salt bridges: H:R.166, C:R.166
- 8 x IMP: INOSINIC ACID(Non-covalent)
IMP.4: 22 residues within 4Å:- Chain A: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.5
14 PLIP interactions:14 interactions with chain A- Hydrogen bonds: A:S.73, A:R.327, A:S.334, A:D.369, A:G.370, A:G.371, A:G.392, A:S.393, A:S.393, A:S.393, A:M.419, A:G.420, A:S.421, A:Q.446
IMP.9: 22 residues within 4Å:- Chain B: S.73, M.75, N.308, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, Q.446, G.447
- Ligands: NAD.10
14 PLIP interactions:14 interactions with chain B- Hydrogen bonds: B:S.73, B:N.308, B:R.327, B:S.334, B:D.369, B:D.369, B:G.371, B:G.392, B:S.393, B:S.393, B:S.393, B:M.419, B:G.420, B:Q.446
IMP.13: 22 residues within 4Å:- Chain C: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, I.372, M.390, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.14
15 PLIP interactions:15 interactions with chain C- Hydrogen bonds: C:S.73, C:S.73, C:N.308, C:R.327, C:S.334, C:S.334, C:D.369, C:G.371, C:G.392, C:S.393, C:S.393, C:M.419, C:G.420, C:S.421, C:Q.446
IMP.18: 21 residues within 4Å:- Chain D: S.73, M.75, R.327, G.333, S.334, C.336, D.369, G.370, G.371, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.19
12 PLIP interactions:12 interactions with chain D- Hydrogen bonds: D:S.73, D:S.73, D:R.327, D:S.334, D:D.369, D:G.371, D:G.392, D:S.393, D:M.419, D:G.420, D:S.421, D:Q.446
IMP.23: 20 residues within 4Å:- Chain E: S.73, M.75, G.333, S.334, I.335, C.336, D.369, G.370, G.371, M.390, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.24
14 PLIP interactions:14 interactions with chain E- Hydrogen bonds: E:S.334, E:D.369, E:G.370, E:G.371, E:G.392, E:S.393, E:S.393, E:S.393, E:S.393, E:Y.416, E:M.419, E:G.420, E:S.421, E:Q.446
IMP.28: 20 residues within 4Å:- Chain F: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, Q.446
- Ligands: NAD.29
12 PLIP interactions:12 interactions with chain F- Hydrogen bonds: F:R.327, F:S.334, F:D.369, F:G.371, F:G.392, F:S.393, F:S.393, F:S.393, F:Y.416, F:M.419, F:G.420, F:Q.446
IMP.32: 23 residues within 4Å:- Chain G: S.73, M.75, N.308, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.33
15 PLIP interactions:15 interactions with chain G- Hydrogen bonds: G:S.73, G:N.308, G:R.327, G:S.334, G:D.369, G:G.371, G:G.392, G:S.393, G:S.393, G:S.393, G:Y.416, G:M.419, G:G.420, G:S.421, G:Q.446
IMP.37: 22 residues within 4Å:- Chain H: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.38
15 PLIP interactions:15 interactions with chain H- Hydrogen bonds: H:S.73, H:R.327, H:R.327, H:S.334, H:D.369, H:G.370, H:G.371, H:G.392, H:S.393, H:S.393, H:Y.416, H:M.419, H:G.420, H:S.421, H:Q.446
- 8 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.5: 17 residues within 4Å:- Chain A: T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, G.329, M.330, G.331, M.419, G.420, Q.446
- Chain D: T.50, Q.474
- Ligands: IMP.4
12 PLIP interactions:11 interactions with chain A, 1 interactions with chain D- Hydrogen bonds: A:T.257, A:E.259, A:D.279, A:S.281, A:N.308, A:G.329, A:G.331, D:Q.474
- Salt bridges: A:H.258
- pi-Stacking: A:H.258, A:F.287, A:F.287
NAD.10: 17 residues within 4Å:- Chain A: Q.474
- Chain B: H.98, T.257, H.258, D.279, S.281, F.287, N.308, G.329, M.330, G.331, C.336, T.338, M.419, G.420, Q.446
- Ligands: IMP.9
17 PLIP interactions:16 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:T.338, B:Q.446
- Hydrogen bonds: B:H.98, B:T.257, B:T.257, B:D.279, B:S.281, B:S.281, B:N.308, B:G.331, B:Q.446, A:Q.474
- Salt bridges: B:H.258
- pi-Stacking: B:H.258, B:H.258, B:F.287, B:F.287
NAD.14: 18 residues within 4Å:- Chain B: T.50, Q.474
- Chain C: H.98, T.257, H.258, D.279, S.280, S.281, F.287, N.308, G.329, M.330, G.331, D.369, M.419, G.420, Q.446
- Ligands: IMP.13
15 PLIP interactions:14 interactions with chain C, 1 interactions with chain B- Hydrogen bonds: C:T.257, C:T.257, C:H.258, C:E.259, C:D.279, C:S.281, C:G.329, C:G.331, C:Q.446, B:Q.474
- Salt bridges: C:H.258
- pi-Stacking: C:F.287, C:F.287
- pi-Cation interactions: C:H.258, C:H.258
NAD.19: 16 residues within 4Å:- Chain D: T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, G.329, M.330, G.331, D.369, M.419, G.420, Q.446
- Ligands: IMP.18
11 PLIP interactions:11 interactions with chain D- Hydrogen bonds: D:E.259, D:E.259, D:D.279, D:S.281, D:N.308, D:G.329, D:G.331
- Salt bridges: D:H.258
- pi-Stacking: D:F.287
- pi-Cation interactions: D:H.258, D:H.258
NAD.24: 18 residues within 4Å:- Chain E: T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, G.329, M.330, G.331, T.338, D.369, M.419, G.420, Q.446
- Chain H: Q.474
- Ligands: IMP.23
13 PLIP interactions:12 interactions with chain E, 1 interactions with chain H- Hydrophobic interactions: E:T.338
- Hydrogen bonds: E:T.257, E:E.259, E:D.279, E:S.281, E:G.329, E:G.331, H:Q.474
- Salt bridges: E:H.258
- pi-Stacking: E:F.287, E:F.287
- pi-Cation interactions: E:H.258, E:H.258
NAD.29: 17 residues within 4Å:- Chain E: Q.474
- Chain F: H.98, T.257, H.258, D.279, S.280, S.281, F.287, N.308, G.329, M.330, G.331, T.338, M.419, G.420, Q.446
- Ligands: IMP.28
13 PLIP interactions:12 interactions with chain F, 1 interactions with chain E- Hydrophobic interactions: F:T.338, F:Q.446
- Hydrogen bonds: F:H.98, F:T.257, F:E.259, F:D.279, F:S.281, F:G.331, E:Q.474
- Salt bridges: F:H.258
- pi-Stacking: F:H.258, F:F.287, F:F.287
NAD.33: 20 residues within 4Å:- Chain F: T.50, Q.474
- Chain G: H.98, T.257, H.258, E.259, D.279, S.280, S.281, F.287, N.308, G.329, M.330, G.331, C.336, D.369, M.419, G.420, Q.446
- Ligands: IMP.32
12 PLIP interactions:11 interactions with chain G, 1 interactions with chain F- Hydrogen bonds: G:T.257, G:D.279, G:S.281, G:S.281, G:G.329, G:G.331, G:Q.446, F:Q.474
- Salt bridges: G:H.258
- pi-Stacking: G:F.287, G:F.287
- pi-Cation interactions: G:H.258
NAD.38: 16 residues within 4Å:- Chain G: Q.474
- Chain H: H.98, T.257, H.258, D.279, S.280, S.281, F.287, N.308, G.329, M.330, G.331, M.419, G.420, Q.446
- Ligands: IMP.37
12 PLIP interactions:1 interactions with chain G, 11 interactions with chain H- Hydrogen bonds: G:Q.474, H:E.259, H:D.279, H:S.281, H:N.308, H:G.329, H:G.331
- Salt bridges: H:H.258
- pi-Stacking: H:F.287, H:F.287
- pi-Cation interactions: H:H.258, H:H.258
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Johnson, M.C. et al., Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation. Elife (2020)
- Release Date
- 2020-03-25
- Peptides
- Inosine-5'-monophosphate dehydrogenase 2: ABCDEFGHIJKLMNOP
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
MJ
NK
OL
PM
IN
JO
KP
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-16-mer
- Ligands
- 12 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 10 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 8 x IMP: INOSINIC ACID(Non-covalent)
- 8 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Johnson, M.C. et al., Cryo-EM structures demonstrate human IMPDH2 filament assembly tunes allosteric regulation. Elife (2020)
- Release Date
- 2020-03-25
- Peptides
- Inosine-5'-monophosphate dehydrogenase 2: ABCDEFGHIJKLMNOP
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
MJ
NK
OL
PM
IN
JO
KP
L